Laser treatment improved the appearance of acne scars in Asians
Study assesses picosecond laser coupled with microlens array for the treatment of atrophic acne...
Read More
Tag: Dermatology
Aerolase Inaugurates Skin of Color Forum, Furthering Its Leadership in Skin of Color Dermatology
For the latest research and practical pearls on overcoming the perennial dermatological challenges...
Read MoreFDA approves Libtayo® (cemiplimab-rwlc) as first and only treatment for advanced cutaneous squamous cell carcinoma
The U.S. Food and Drug Administration (FDA) has approved Libtayo® (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates...
Read MoreNovartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma
Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E...
Read More
SkinCeuticals introduces Glycolic 10 Renew Overnight to restore skin’s natural glow and improve skin texture
SkinCeuticals unveils Glycolic 10 Renew Overnight – the latest addition to the Correct...
Read MorePhase 3 results for Sun Pharma’s investigational psoriasis medicine, tildrakizumab
Sun Pharma has announced late-breaking data from two pivotal Phase-3 clinical trials (reSURFACE 1 and 2) achieving the primary endpoint with tildrakizumab, an investigational IL-23p19 inhibitor, in patients with...
Read MoreICAD 2016: ‘The’ Asian Milestone in Aesthetic and Anti-ageing Dermatology
PRIME previews the 7th International Congress in Aesthetic Dermatology (ICAD 2016), taking place in Bangkok, Thailand, on 24–26 November 2016. ICAD 2016 will be held at the Bangkok Convention Centre at...
Read MoreAllergan acquires medical dermatology and aesthetic medicine company Anterios to expand neurotoxin pipeline
Acquisition adds global rights to novel NDS™ platform topical delivery technology and ANT-1207, investigational botulinum toxin type A product
Read More
Jan/Feb 2023 Issue
